Stock SDGR SCHRÖDINGER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Schrödinger, Inc.

Equities

SDGR

US80810D1037

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
21.64 USD +3.05% Intraday chart for Schrödinger, Inc. -7.80% -39.55%
May. 13 Ajax Therapeutics, Inc. announced that it has received $95 million in funding from a group of investors CI
May. 07 Ansys Partners With Schrodinger to Accelerate Materials Development MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Schrodinger to Present at Jefferies Global Healthcare Conference
AQ
Schrödinger to Present at Jefferies Global Healthcare Conference
BU
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
Schrödinger Reports First Quarter 2024 Financial Results
BU
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
BU
Schrodinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
AQ
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
BU
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results
BU
Schrödinger : Schrödinger Corporate Presentation
PU
Schrodinger to Participate in Upcoming Investor Conferences
AQ
Schrödinger to Participate in Upcoming Investor Conferences
BU
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BU
Schrodinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
AQ
Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28
BU
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SDGR Stock
  4. News Schrödinger, Inc.
  5. Press Releases